Toth Financial Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.77K	Sell	173 -32	-16%	-$1.87K	﹤0.01%	562
2025 Q4	$12.2K	Hold	205	–	–	﹤0.01%	528
2025 Q3	$11.1K	Hold	205	–	–	﹤0.01%	528
2025 Q2	$11.3K	Sell	205 -5,900	-97%	-$347K	﹤0.01%	479
2025 Q1	$432K	Buy	6,105 +5,900	+2,878%	+$397K	0.05%	164
2024 Q4	$13.5K	Hold	205	–	–	﹤0.01%	434
2024 Q3	$14.4K	Hold	205	–	–	﹤0.01%	419
2024 Q2	$16.9K	Hold	205	–	–	﹤0.01%	411
2024 Q1	$17.9K	Hold	205	–	–	﹤0.01%	395
2023 Q4	$19.8K	Hold	205	–	–	﹤0.01%	392
2023 Q3	$18.1K	Hold	205	–	–	﹤0.01%	382
2023 Q2	$17.8K	Hold	205	–	–	﹤0.01%	405
2023 Q1	$19.9K	Hold	205	–	–	﹤0.01%	385
2022 Q4	$21.2K	Hold	205	–	–	﹤0.01%	373
2022 Q3	$17K	Sell	205 -95	-32%	-$8.46K	﹤0.01%	390
2022 Q2	$25K	Sell	300 -20	-6%	-$1.59K	﹤0.01%	342
2022 Q1	$25K	Hold	320	–	–	﹤0.01%	358
2021 Q4	$28K	Hold	320	–	–	﹤0.01%	351
2021 Q3	$25K	Hold	320	–	–	﹤0.01%	366
2021 Q2	$27K	Hold	320	–	–	﹤0.01%	338
2021 Q1	$24K	Hold	320	–	–	﹤0.01%	358
2020 Q4	$28K	Hold	320	–	–	﹤0.01%	300
2020 Q3	$24K	Hold	320	–	–	﹤0.01%	291
2020 Q2	$39K	Hold	320	–	–	0.01%	238
2020 Q1	$27K	Buy	320 +20	+7%	+$1.72K	0.01%	214
2019 Q4	$25K	Hold	300	–	–	0.01%	243
2019 Q3	$20K	Hold	300	–	–	﹤0.01%	275
2019 Q2	$26K	Hold	300	–	–	0.01%	255
2019 Q1	$27K	Sell	300 -100	-25%	-$9.27K	0.01%	240
2018 Q4	$34K	Hold	400	–	–	0.01%	208
2018 Q3	$39K	Hold	400	–	–	0.01%	216
2018 Q2	$38K	Hold	400	–	–	0.01%	222
2018 Q1	$32K	Hold	400	–	–	0.01%	230
2017 Q4	$36K	Buy	+400	New	+$34.8K	0.01%	230